Lower specific infectivity of protease-resistant prion protein generated in cell-free reactions

被引:50
作者
Klingeborn, Mikael [1 ]
Race, Brent [1 ]
Meade-White, Kimberly D. [1 ]
Chesebro, Bruce [1 ]
机构
[1] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA
关键词
Creutzfeldt-Jakob disease; amyloid; neurodegeneration; protein polymerization; protein aggregation; CHRONIC WASTING DISEASE; IN-VITRO; SPONGIFORM ENCEPHALOPATHIES; SCRAPIE AGENT; CYCLIC AMPLIFICATION; INCUBATION PERIOD; TRANSGENIC MICE; BRAIN; ASSAY; REPLICATION;
D O I
10.1073/pnas.1111255108
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prions are unconventional infectious agents that cause transmissible spongiform encephalopathy (TSE) diseases, or prion diseases. The biochemical nature of the prion infectious agent remains unclear. Previously, using a protein misfolding cyclic amplification (PMCA) reaction, infectivity and disease-associated protease-resistant prion protein (PrPres) were both generated under cell-free conditions, which supported a nonviral hypothesis for the agent. However, these studies lacked comparative quantitation of both infectivity titers and PrPres, which is important both for biological comparison with in vivo-derived infectivity and for excluding contamination to explain the results. Here during four to eight rounds of PMCA, end-point dilution titrations detected a > 320-fold increase in infectivity versus that in controls. These results provide strong support for the hypothesis that the agent of prion infectivity is not a virus. PMCA-generated samples caused the same clinical disease and neuropathology with the same rapid incubation period as the input brain-derived scrapie samples, providing no evidence for generation of a new strain in PMCA. However, the ratio of the infectivity titer to the amount of PrPres (specific infectivity) was much lower in PMCA versus brain-derived samples, suggesting the possibility that a substantial portion of PrPres generated in PMCA might be noninfectious.
引用
收藏
页码:E1244 / E1253
页数:10
相关论文
共 49 条
[11]   Prion protein and the transmissible spongiform encephalopathy diseases [J].
Chesebro, B .
NEURON, 1999, 24 (03) :503-506
[12]   Introduction to the transmissible spongiform encephalopathies or prion diseases [J].
Chesebro, B .
BRITISH MEDICAL BULLETIN, 2003, 66 :1-20
[13]   Prion diseases - BSE and prions: Uncertainties about the agent [J].
Chesebro, B .
SCIENCE, 1998, 279 (5347) :42-43
[14]   Prion detection by an amyloid seeding assay [J].
Colby, David W. ;
Zhang, Qiang ;
Wang, Shuyi ;
Groth, Darlene ;
Legname, Giuseppe ;
Riesner, Detlev ;
Prusiner, Stanley B. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) :20914-20919
[15]   Formation of native prions from minimal components in vitro [J].
Deleault, Nathan R. ;
Harris, Brent T. ;
Rees, Judy R. ;
Supattapone, Surachai .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (23) :9741-9746
[16]   Species-Dependent Differences in Cofactor Utilization for Formation of the Protease-Resistant Prion Protein in Vitro [J].
Deleault, Nathan R. ;
Kascsak, Richard ;
Geoghegan, James C. ;
Supattapone, Surachai .
BIOCHEMISTRY, 2010, 49 (18) :3928-3934
[17]   SCRAPIE INFECTIVITY, FIBRILS AND LOW-MOLECULAR WEIGHT PROTEIN [J].
DIRINGER, H ;
GELDERBLOM, H ;
HILMERT, H ;
OZEL, M ;
EDELBLUTH, C ;
KIMBERLIN, RH .
NATURE, 1983, 306 (5942) :476-478
[18]   Agents that cause transmissible subacute spongiform encephalopathies [J].
Dormont, D .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (01) :3-8
[19]  
Dougherty R., 1964, Techniques in experimental virology, P169
[20]   Accelerated high fidelity prion amplification within and across prion species barriers [J].
Green, Kristi M. ;
Castilla, Joaquin ;
Seward, Tanya S. ;
Napier, Dana L. ;
Jewell, Jean E. ;
Soto, Claudio ;
Telling, Glenn C. .
PLOS PATHOGENS, 2008, 4 (08)